Abbott Laboratories buy UBS Group AG
Start price
23.01.25
/
50%
€113.50
Target price
23.01.26
€142.08
Performance (%)
-5.83%
Price
12.12.25
€106.88
Summary
This prediction is currently active. With a performance of -5.83%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 23.01.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -0.447% | -0.447% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $146.00 to $148.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€108.52
17.10.24
17.10.24
€134.85
17.10.25
17.10.25
1.35%
18.10.25
18.10.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.04
20.04.23
20.04.23
€118.42
20.04.24
20.04.24
-1.53%
21.04.24
21.04.24